InvestorsHub Logo
Followers 16
Posts 1854
Boards Moderated 0
Alias Born 06/24/2014

Re: None

Tuesday, 10/18/2016 8:10:07 AM

Tuesday, October 18, 2016 8:10:07 AM

Post# of 1089
NORWOOD, MA--(Marketwired - October 18, 2016) - Corbus Pharmaceuticals Holdings, Inc. (CRBP) ("Corbus" or the "Company"), a clinical stage drug development company targeting rare, chronic, serious inflammatory and fibrotic diseases, announced today that the European Commission has granted Orphan Designation in the European Union for the Company's novel synthetic oral endocannabinoid-mimetic drug, Resunab, for the treatment of cystic fibrosis ("CF").

my way or the highway

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CRBP News